Merck & Co (NYSE: MRK)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $110.53
-
Support level$98.17
-
Resistance levelN/A
-
Beta0.3
-
RSI (14-day)84.3
- MRK is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- MRK is one of this month's top performers with a return of 13.2 percent, beating 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- With RSI > 70, MRK is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $73.47 | $110.99 | 99.0% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $86.07 | $98.42 | $104.63 | $107.76 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.2%
-
In the next month13.1%
-
In the next year57.6%
| Period | Value |
|---|---|
| Historical (5 year) | 23.0% |
| Last month | 22.5% |
| Current estimate | 26.3% |
| Next month forecast | 23.1% |